Joseph G. Dolan

Joseph G. Dolan

Hematology | Oncology

100 North Mario Capecchi Drive
Suite 1400
Salt Lake City, UT 84113

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Refractory infantile IPEX with Treg-restricted FOXP3null expression caused by a novel variant in FOXP3.

Refractory infantile IPEX with Treg-restricted FOXP3null expression caused by a novel variant in FOXP3.

Journal: Journal of human immunity

Published: November 25, 2025

CD19 CAR T-cell outcomes in relapsed/refractory extramedullary B-ALL: a multisite, retrospective cohort review.

CD19 CAR T-cell outcomes in relapsed/refractory extramedullary B-ALL: a multisite, retrospective cohort review.

Journal: Blood advances

Published: October 01, 2025

How I use next-generation sequencing-MRD to plan approach and prevent relapse after HCT for children and adults with ALL.

How I use next-generation sequencing-MRD to plan approach and prevent relapse after HCT for children and adults with ALL.

Journal: Blood

Published: February 29, 2024

Addressing spiritual distress in pediatric oncology.

Addressing spiritual distress in pediatric oncology.

Journal: Pediatric blood & cancer

Published: November 02, 2021

Hematopathologic Correlates of CAR T-Cell Therapy.

Hematopathologic Correlates of CAR T-Cell Therapy.

Journal: Clinics in laboratory medicine

Published: July 26, 2021

CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials.

CD19-targeted chimeric antigen receptor T-cell therapy for CNS relapsed or refractory acute lymphocytic leukaemia: a post-hoc analysis of pooled data from five clinical trials.

Journal: The Lancet. Haematology

Published: March 08, 2021

Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial.

Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 08, 2021

Chimeric antigen receptor T cell therapy for pediatric and young adult B cell acute lymphoblastic leukemia.

Chimeric antigen receptor T cell therapy for pediatric and young adult B cell acute lymphoblastic leukemia.

Journal: Expert review of clinical immunology

Published: September 25, 2020

Association of psychological distress and religious coping tendencies in parents of children recently diagnosed with cancer: A cross-sectional study.

Association of psychological distress and religious coping tendencies in parents of children recently diagnosed with cancer: A cross-sectional study.

Journal: Pediatric blood & cancer

Published: September 23, 2020

Emergent Radiation for Leukemic Optic Nerve Infiltration in a Child Receiving Intrathecal Methotrexate.

Emergent Radiation for Leukemic Optic Nerve Infiltration in a Child Receiving Intrathecal Methotrexate.

Journal: Practical radiation oncology

Published: December 28, 2018

Gain-of-Function STAT1 Mutation With Familial Lymphadenopathy and Hodgkin Lymphoma.

Gain-of-Function STAT1 Mutation With Familial Lymphadenopathy and Hodgkin Lymphoma.

Journal: Frontiers in pediatrics

Published: December 01, 2018

Showing 1-11 of 11

Last Updated: 09/26/2026